1. Home
  2. BRTX vs GP Comparison

BRTX vs GP Comparison

Compare BRTX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • GP
  • Stock Information
  • Founded
  • BRTX 1997
  • GP 2010
  • Country
  • BRTX United States
  • GP Canada
  • Employees
  • BRTX 11
  • GP N/A
  • Industry
  • BRTX Managed Health Care
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • BRTX Health Care
  • GP Consumer Discretionary
  • Exchange
  • BRTX Nasdaq
  • GP Nasdaq
  • Market Cap
  • BRTX 13.7M
  • GP 12.7M
  • IPO Year
  • BRTX N/A
  • GP 2020
  • Fundamental
  • Price
  • BRTX $1.67
  • GP $0.45
  • Analyst Decision
  • BRTX Strong Buy
  • GP Strong Buy
  • Analyst Count
  • BRTX 1
  • GP 2
  • Target Price
  • BRTX $18.00
  • GP $2.33
  • AVG Volume (30 Days)
  • BRTX 27.4K
  • GP 38.9K
  • Earning Date
  • BRTX 05-14-2025
  • GP 06-27-2025
  • Dividend Yield
  • BRTX N/A
  • GP N/A
  • EPS Growth
  • BRTX N/A
  • GP N/A
  • EPS
  • BRTX N/A
  • GP N/A
  • Revenue
  • BRTX $401,000.00
  • GP $20,656,035.00
  • Revenue This Year
  • BRTX $446.88
  • GP N/A
  • Revenue Next Year
  • BRTX $39.53
  • GP $94.25
  • P/E Ratio
  • BRTX N/A
  • GP N/A
  • Revenue Growth
  • BRTX 175.03
  • GP N/A
  • 52 Week Low
  • BRTX $1.03
  • GP $0.41
  • 52 Week High
  • BRTX $2.55
  • GP $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 41.86
  • GP 48.02
  • Support Level
  • BRTX $1.66
  • GP $0.44
  • Resistance Level
  • BRTX $1.88
  • GP $0.52
  • Average True Range (ATR)
  • BRTX 0.08
  • GP 0.03
  • MACD
  • BRTX -0.01
  • GP 0.00
  • Stochastic Oscillator
  • BRTX 8.33
  • GP 36.18

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: